Athira’s Fosgonimeton Fails In Phase II/III LIFT-AD Trial, Future Uncertain

Phase I Next-Gen Drug May Become Priority

 
• By Mandy Jackson
  
Mist at the potential end of a road
It's unclear whether the LIFT-AD failure is the end of the road for Athira's drug • Source: Shutterstock

More from Clinical Trials

More from R&D